BG63261B1 - Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност - Google Patents

Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност Download PDF

Info

Publication number
BG63261B1
BG63261B1 BG101570A BG10157097A BG63261B1 BG 63261 B1 BG63261 B1 BG 63261B1 BG 101570 A BG101570 A BG 101570A BG 10157097 A BG10157097 A BG 10157097A BG 63261 B1 BG63261 B1 BG 63261B1
Authority
BG
Bulgaria
Prior art keywords
ethyl
erythromycin
oxime
hexylamino
formula
Prior art date
Application number
BG101570A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101570A (en
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Group S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S.P.A. filed Critical Zambon Group S.P.A.
Publication of BG101570A publication Critical patent/BG101570A/xx
Publication of BG63261B1 publication Critical patent/BG63261B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG101570A 1994-12-13 1997-06-05 Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност BG63261B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (2)

Publication Number Publication Date
BG101570A BG101570A (en) 1998-02-27
BG63261B1 true BG63261B1 (bg) 2001-07-31

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101570A BG63261B1 (bg) 1994-12-13 1997-06-05 Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност

Country Status (35)

Country Link
US (1) US5847092A (uk)
EP (1) EP0797579B1 (uk)
JP (1) JPH10510520A (uk)
KR (1) KR100367559B1 (uk)
CN (1) CN1046535C (uk)
AP (1) AP739A (uk)
AT (1) ATE190620T1 (uk)
AU (1) AU690791B2 (uk)
BG (1) BG63261B1 (uk)
BR (1) BR9510015A (uk)
CA (1) CA2207029A1 (uk)
CZ (1) CZ289943B6 (uk)
DE (1) DE69515694T2 (uk)
DK (1) DK0797579T3 (uk)
EE (1) EE03401B1 (uk)
ES (1) ES2144154T3 (uk)
FI (1) FI972493A (uk)
GE (1) GEP20012391B (uk)
GR (1) GR3033622T3 (uk)
HU (1) HU220631B1 (uk)
IT (1) IT1276901B1 (uk)
LT (1) LT4276B (uk)
LV (1) LV11898B (uk)
MD (1) MD1788G2 (uk)
NO (1) NO309816B1 (uk)
NZ (1) NZ297446A (uk)
OA (1) OA10491A (uk)
PL (1) PL182053B1 (uk)
PT (1) PT797579E (uk)
RO (1) RO116282B1 (uk)
RU (1) RU2152951C1 (uk)
SI (1) SI9520124A (uk)
TJ (1) TJ306B (uk)
UA (1) UA48958C2 (uk)
WO (1) WO1996018633A1 (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DK90788A (da) 1987-02-24 1988-08-25 Beecham Group Plc Erythromycinderivater
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
BG101570A (en) 1998-02-27
LV11898B (en) 1998-03-20
BR9510015A (pt) 1997-10-28
AU690791B2 (en) 1998-04-30
AP739A (en) 1999-03-24
CA2207029A1 (en) 1996-06-20
CN1169727A (zh) 1998-01-07
KR100367559B1 (ko) 2003-04-21
FI972493A0 (fi) 1997-06-12
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
RO116282B1 (ro) 2000-12-29
EE9700124A (et) 1997-12-15
NZ297446A (en) 1999-06-29
US5847092A (en) 1998-12-08
GEP20012391B (en) 2001-03-25
MD970243A (en) 1999-05-31
RU2152951C1 (ru) 2000-07-20
PL182053B1 (pl) 2001-10-31
EP0797579A1 (en) 1997-10-01
PL320688A1 (en) 1997-10-27
CZ178697A3 (en) 1997-12-17
TJ306B (en) 2001-08-06
SI9520124A (sl) 1998-04-30
ATE190620T1 (de) 2000-04-15
JPH10510520A (ja) 1998-10-13
CZ289943B6 (cs) 2002-04-17
MX9704253A (es) 1997-09-30
HU220631B1 (hu) 2002-03-28
UA48958C2 (uk) 2002-09-16
NO309816B1 (no) 2001-04-02
PT797579E (pt) 2000-08-31
GR3033622T3 (en) 2000-10-31
DE69515694D1 (de) 2000-04-20
DE69515694T2 (de) 2000-10-26
DK0797579T3 (da) 2000-06-05
NO972702D0 (no) 1997-06-12
LT4276B (lt) 1998-01-26
EP0797579B1 (en) 2000-03-15
ES2144154T3 (es) 2000-06-01
ITMI942496A0 (it) 1994-12-13
LV11898A (lv) 1997-12-20
AP9700989A0 (en) 1997-07-31
HUT77126A (hu) 1998-03-02
IT1276901B1 (it) 1997-11-03
WO1996018633A1 (en) 1996-06-20
NO972702L (no) 1997-08-13
AU4260396A (en) 1996-07-03
ITMI942496A1 (it) 1996-06-13
CN1046535C (zh) 1999-11-17
FI972493A (fi) 1997-06-12
OA10491A (en) 2002-04-10
LT97116A (en) 1997-10-27
EE03401B1 (et) 2001-04-16

Similar Documents

Publication Publication Date Title
JP2657132B2 (ja) アジスロマイシンaのo−メチル誘導体、その製造法、その製造中間体及びそれを含有する抗菌剤組成物
EP0885234B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2473525A1 (fr) Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4518590A (en) 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
BG63261B1 (bg) Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност
RU2320668C2 (ru) 9а-азалиды с противовоспалительной активностью
JPH07252292A (ja) 9−デオキソ−9a−アザ−9a−ホモエリスロマイシンAの9a−N−(N′−カルバモイル)及び9a−N−(N′−チオカルバモイル)誘導体
EP0503932B1 (en) 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof
MXPA97004253A (en) Derivatives of 9-0-oxima of erythromycin or dotated with antibioot activity
CH628906A5 (en) Semi-synthetic derivatives of 4''-erythromycin A and medicinal products containing them
KR20050085555A (ko) 아잘라이드 계열의 신규한 반합성 마크로라이드 항생제
EP1100806B1 (en) Erythromycin derivative with antibiotic activity
FI68404B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4"deoxi-4"-aminoerytromycin-a-derivat
KR100530017B1 (ko) 옥사졸리디논 유도체 화합물 및 그의 제조방법 및 그를 함유하는 항균제 조성물
KR100463111B1 (ko) 신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
JPH03115293A (ja) マクロライド系抗生物質